Anzeige
Mehr »
Login
Donnerstag, 23.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Amazon investiert Millionen in Kernenergie - so können Sie sich früh positionieren!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
951 Leser
Artikel bewerten:
(2)

Sumo Logic, Inc.: Sumo Logic Marks Milestone in OpenTelemetry Posture Removing Complexity in Collection for Faster Time to Insights

Finanznachrichten News

Reinforces commitment to OpenTelemetry strategy, removes complexity in collection and normalization across data types for OTel native experiences

AMSTERDAM, April 18, 2023 (GLOBE NEWSWIRE) -- KubeCon + CloudNativeCon Europe 2023 - Sumo Logic (NASDAQ: SUMO), the SaaS analytics platform to enable reliable and secure cloud-native applications, today announced it has taken steps to remove complexity from data collection, improved normalization of data, and consolidated collection agents with OpenTelemetry.

Sumo Logic was purpose-built to manage and analyze data from any source. Today, Sumo Logic extends that legacy by adopting OpenTelemetry as its de facto collection strategy to remove complexity in the collection and normalization of data. With Sumo Logic Distro for OT, a native OTel solution, customers no longer face vendor lock-in and can apply Sumo Logic flexibility and analytics to their vendor of choice.

"Sumo Logic?has made a commitment to its customers and the community to develop and deliver on OTel-native collection so that customers can realize value, quickly," said Erez Barak, VP of Product Development for Observability, Sumo Logic. "The enhancements announced today will make it possible for?Sumo Logic to deliver choice and flexibility while continuing to provide comprehensive infrastructure and application monitoring. The best OTel-native experiences run on Sumo Logic."

Ease of Onboarding Data Using OpenTelemetry

With nearly 30 apps related to database, server, or infrastructure monitoring powered by OTel, Sumo Logic Distro for OT provides a single collector for telemetry. Now, with support for Windows, customers using Sumo Logic Distro for OT can gather logs, metrics, and traces from Windows, Linux and MacOS operating systems, which can be configured utilizing the new onboarding workflows.

A single, OTel-based collection strategy is important for application observability and infrastructure monitoring. Onboarding data and setting up collection from various sources can be complex as users juggle disparate backends or libraries and may be limited by proprietary tools. Sumo Logic's unified agent makes it easier to consolidate into one platform for observability use cases instead of disparate monitoring tools for logs or APM. Through a single app installation workflow for logs, metrics and traces, Sumo Logic makes it easier for developers to harness data and takes the complexity out of deploying OpenTelemetry as a collection strategy.

Sumo Logic also reduces the number of manual steps in the data onboarding process. Each step - Collector Setup, Source Configuration, Dashboard Setup - is now folded into a single workflow allowing users to onboard data in under 5 minutes. By standardizing on OTel-native collection, developers get a simplified installation to onboard data and set up data collection on Sumo Logic.

Additional Resources:

  • Blog: OpenTelemetry-powered infrastructure monitoring: isolate and fix issues in minutes (https://www.sumologic.com/blog/otel-powered-infrastructure-monitoring/)
  • Blog: How to monitor MySQL performance metrics in minutes (https://www.sumologic.com/blog/mysql-performance-monitoring/)
  • Technical Docs: Sumo Logic OpenTelemetry Collector (https://help.sumologic.com/docs/send-data/opentelemetry-collector/)

About Sumo Logic
Sumo Logic, Inc..

Sumo Logic is a trademark or registered trademark of Sumo Logic in the United States and in foreign countries. All other company and product names may be trademarks or registered trademarks of their respective owners.

Any information regarding offerings, updates, functionality, or other modifications, including release dates, is subject to change without notice. The development, release, and timing of any offering, update, functionality, or modification described herein remains at the sole discretion of Sumo Logic, and should not be relied upon in making a purchase decision, nor as a representation, warranty, or commitment to deliver specific offerings, updates, functionalities, or modifications in the future.

Media Contacts
Carmen Harris, Sumo Logic
charris@sumologic.com

Jenna Shikoff, RH Strategic
SumoLogicPR@RHStrategic.com


© 2023 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.